{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:28:59Z","timestamp":1794000539801,"version":"4.8.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Evidence exists as to the criticality of the first 24\u2009h in the management of cerebral malaria. The morbidity and the mortality rate (35%) with the current intravenous monotherapy for the initial treatment of cerebral malaria are unacceptably high. Combination therapy and a shorter course of effective medication have been shown to improve outcomes in human participants in the treatment of other diseases. This study outlines a protocol to conduct a triple blinded parallel randomized controlled trial on cerebral malaria using dual intravenous medications compared to the current standard of monotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a parallel multi-site randomized controlled superiority triple blinded trial consisting of intravenous artesunate plus quinine and a control arm of intravenous artesunate only. Eligible and assenting children aged 6\u2009months to 17\u2009years will be recruited from 4 tertiary hospitals by random selection from the list of tertiary hospitals in Nigeria. Participants will be randomized and assigned in parallel into two arms using random numbers generated from GraphPad Prism (version 9) by a clinical pharmacologist who has no link with the investigators, the patients, or the statistician. The primary measurable outcome is survival at 12, 24, and 48\u2009h post-randomization. A composite secondary outcome consists of the number of children that regained consciousness, parasitaemia and defervescence at 12 and 24\u2009h post-randomization and haematological and inflammatory markers at 24 and 48\u2009h post-randomization. Adverse events both solicited and unsolicited are recorded all through the study post-randomization. The study is approved by the State Research Ethics Review Committee. Data analysis will be performed in GraphPad Prism version 9.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The outcome of this analysis will give insight into the efficacy and safety of dual intravenous antimalaria in the treatment of cerebral malaria among Nigerian children compared with the standard of care. The safety profile of this intervention will also be highlighted. This may help inform physicians on the optimal treatment for cerebral malaria to improve outcomes and reduce recrudescence and treatment failure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Pan Africa Clinical Trial Registry <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/pactr.samrc.ac.za\/Researcher\/ManageTrials.aspx\">PACTR202102893629864<\/jats:ext-link>. 23\/02\/2021.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-021-05634-6","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T11:51:56Z","timestamp":1634730716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of dual intravenous artesunate plus quinine compared to intravenous artesunate for cerebral malaria in a triple blinded parallel multisite randomized controlled trial in Nigerian children: DUAL PAQ TRIAL Protocol"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0109-4435","authenticated-orcid":false,"given":"Michael Abel","family":"Alao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adebola Emmanuel","family":"Orimadegun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olayinka Rasheed","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abayomi O.","family":"Oyenuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adanze Onyenonachi","family":"Asinobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Adedosu","family":"Gbadero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifeoma Joy","family":"Okoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Okechukwu","family":"Nna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"5634_CR1","doi-asserted-by":"publisher","unstructured":"White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu OA, Dondorp AM. Erratum: Malaria (The Lancet (2014) 383 (723-735)). Lancet. 2014 1;383(9918) DOI: https:\/\/doi.org\/10.1016\/S0140-6736(13)60024-0.","DOI":"10.1016\/S0140-6736(13)60024-0"},{"issue":"9724","key":"5634_CR2","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/S0140-6736(10)60447-3","volume":"375","author":"J Crawley","year":"2010","unstructured":"Crawley J, Chu C, Mtove G, Nosten F. Malaria in children. Lancet. 2010;375(9724):1468\u201381. https:\/\/doi.org\/10.1016\/S0140-6736(10)60447-3.","journal-title":"Lancet"},{"key":"5634_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.brainresbull.2019.01.010","volume":"145","author":"AL Luzolo","year":"2019","unstructured":"Luzolo AL, Ngoyi DM. Cerebral malaria. Brain Res Bull. 2019;145:53\u20138. https:\/\/doi.org\/10.1016\/j.brainresbull.2019.01.010.","journal-title":"Brain Res Bull"},{"issue":"4","key":"5634_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1203\/PDR.0b013e3181eee738","volume":"68","author":"R Idro","year":"2010","unstructured":"Idro R, Marsh K, John CC, Newton CR. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res. 2010;68(4):267\u201374. https:\/\/doi.org\/10.1203\/PDR.0b013e3181eee738.","journal-title":"Pediatr Res"},{"key":"5634_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/B978-0-444-53490-3.00006-6","volume":"114","author":"DG Postels","year":"2013","unstructured":"Postels DG, Birbeck GL. Cerebral malaria. Handb Clin Neurol. 2013;114:91\u2013102. https:\/\/doi.org\/10.1016\/B978-0-444-53490-3.00006-6.","journal-title":"Handb Clin Neurol"},{"issue":"5","key":"5634_CR6","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.ajpath.2012.08.010","volume":"181","author":"HJ Shikani","year":"2012","unstructured":"Shikani HJ, Freeman BD, Lisanti MP, Weiss LM, Tanowitz HB, Desruisseaux MS. Cerebral malaria: we have come a long way. Am J Pathol. 2012;181(5):1484\u201392. https:\/\/doi.org\/10.1016\/j.ajpath.2012.08.010.","journal-title":"Am J Pathol"},{"issue":"6872","key":"5634_CR7","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/415680a","volume":"415","author":"J Sachs","year":"2002","unstructured":"Sachs J, Malaney P. The economic and social burden of malaria. Nature. 2002;415(6872):680\u20135. https:\/\/doi.org\/10.1038\/415680a.","journal-title":"Nature."},{"key":"5634_CR8","unstructured":"World Health Organization. World malaria report 2015. World Health Organization; 2016 Jan 30."},{"key":"5634_CR9","unstructured":"World Health Organization. Guidelines for the treatment of malaria. World Health Organization; 2015 Aug 13."},{"key":"5634_CR10","doi-asserted-by":"publisher","unstructured":"Esu EB, Effa EE, Opie ON, Meremikwu MM. Artemether for severe malaria. Cochrane Database Syst Rev. 2019;6. https:\/\/doi.org\/10.1002\/14651858.CD010678.pub3.","DOI":"10.1002\/14651858.CD010678.pub3"},{"key":"5634_CR11","unstructured":"World Health Organization. Global technical strategy for malaria 2016-2030. World Health Organization; 2015 Nov 4."},{"issue":"9","key":"5634_CR12","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1097\/CCM.0b013e3181eb3ccd","volume":"38","author":"A Kumar","year":"2010","unstructured":"Kumar A, Zarychanski R, Light B, Parrillo J, Maki D, Simon D, et al. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med. 2010;38(9):1773\u201385. https:\/\/doi.org\/10.1097\/CCM.0b013e3181eb3ccd.","journal-title":"Crit Care Med"},{"issue":"8","key":"5634_CR13","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1097\/CCM.0b013e3181e96b91","volume":"38","author":"A Kumar","year":"2010","unstructured":"Kumar A, Safdar N, Kethireddy S, Chateau D. A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic\/meta-regression study. Crit Care Med. 2010;38(8):1651\u201364. https:\/\/doi.org\/10.1097\/CCM.0b013e3181e96b91.","journal-title":"Crit Care Med"},{"issue":"23","key":"5634_CR14","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","volume":"8","author":"RB Mokhtari","year":"2017","unstructured":"Mokhtari RB, Homayouni TS, Baluch N, Morgatskaya E, Kumar S, Das B, et al. Combination therapy in combating cancer. Oncotarget. 2017;8(23):38022\u201343. https:\/\/doi.org\/10.18632\/oncotarget.16723.","journal-title":"Oncotarget."},{"issue":"3","key":"5634_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc9056","volume":"14","author":"I Coquet","year":"2010","unstructured":"Coquet I, Pavie J, Palmer P, Barbier F, Legriel S, Mayaux J, et al. Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era. Crit Care. 2010;14(3):1\u20139. https:\/\/doi.org\/10.1186\/cc9056.","journal-title":"Crit Care"},{"key":"5634_CR16","unstructured":"Federal Ministry of Health Nigeria. A directory of health facilities in Nigeria. Abuja, Nigeria: Federal Ministry of Health Nigeria; 2013."},{"key":"5634_CR17","unstructured":"Federal Ministry of Health Nigeria. Teaching Hospitals: List of all federal teaching hospitals:Available from: https:\/\/www.health.gov.ng\/index.php?option=com_content&view=article&id=136&Itemid=502. Accessed 3 Apr 2021."},{"key":"5634_CR18","doi-asserted-by":"publisher","unstructured":"Sinclair D, Donegan S, Isba R, Lalloo DG. Artesunate versus quinine for treating severe malaria. Cochrane Database Syst Rev. 2012;6. https:\/\/doi.org\/10.1002\/14651858.CD005967.pub4.","DOI":"10.1002\/14651858.CD005967.pub4"},{"issue":"6","key":"5634_CR19","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/0035-9203(92)90137-2","volume":"86","author":"TT Hien","year":"1992","unstructured":"Hien TT, Arnold K, Vinh H, Cuong BM, Phu NH, Chau TT, et al. Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg. 1992;86(6):582\u20133. https:\/\/doi.org\/10.1016\/0035-9203(92)90137-2.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"5634_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4269\/ajtmh.2010.10-0128","volume":"83","author":"A Bartoloni","year":"2010","unstructured":"Bartoloni A, Tomasoni L, Bartalesi F, Galli L, Sani S, Veloci S, et al. Case report: combined intravenous treatment with artesunate and quinine for severe malaria in Italy. Am J Trop Med Hyg. 2010;83(2):274\u20136. https:\/\/doi.org\/10.4269\/ajtmh.2010.10-0128.","journal-title":"Am J Trop Med Hyg"},{"issue":"526","key":"5634_CR21","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1259\/0007-1285-44-526-793","volume":"44","author":"JL Haybittle","year":"1971","unstructured":"Haybittle JL. Repeated assessment of results in clinical trials of cancer treatment. Br J Radiol. 1971 Oct;44(526):793\u20137. https:\/\/doi.org\/10.1259\/0007-1285-44-526-793.","journal-title":"Br J Radiol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05634-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-021-05634-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05634-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T12:12:49Z","timestamp":1634731969000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-021-05634-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5634"],"URL":"https:\/\/doi.org\/10.1186\/s13063-021-05634-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,20]]},"assertion":[{"value":"12 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the State Research Ethics Review Committee (Ref: NREC\/12\/04\/2012), and the trial was also registered (PACTR202102893629864).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"The informed consent form will be redacted before sharing publicly. Patient identifiers will be removed from all documents for public access. The model consent form will be available on request through the corresponding author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"721"}}